Literature DB >> 456410

Convulsant, anticonvulsant and anaesthetic barbiturates. 5-Ethyl-5-(3'-methyl-but-2'-enyl)-barbituric acid and related compounds.

P R Andrews, G P Jones, D Lodge.   

Abstract

Barbiturates derived by minor structural changes to the butenyl sidechain of the convulsant 5-ethyl-5-(3'-methyl-but-2'-enyl)-barbituric acid are almost devoid of convulsant activity, but all have anaesthetic and anticonvulsant effects. Anticonvulsant activity is also observed in the convulsant barbiturate. Increased lipophilic character does not increase anaesthetic potency, only speed of onset, and anticonvulsant activity is reduced in the more lipophilic compounds. The stereochemistry at the 3'-position of the sidechain is vitally important to convulsant activity, and also influences anticonvulsant potency.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 456410     DOI: 10.1016/0014-2999(79)90382-0

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  5 in total

1.  Postsynaptic effects of some central stimulants at the neuromuscular junction.

Authors:  P W Gage; P Sah
Journal:  Br J Pharmacol       Date:  1982-03       Impact factor: 8.739

2.  Actions of pentobarbitone and derivatives with modified 5-butyl substituents on GABA and diazepam binding to rat brain synaptosomal membranes.

Authors:  J H Skerritt; G A Johnston; T Katsikas; J Tabar; G M Nicholson; P R Andrews
Journal:  Neurochem Res       Date:  1983-10       Impact factor: 3.996

Review 3.  Mechanisms of anaesthesia: a review.

Authors:  S H Roth
Journal:  Can Anaesth Soc J       Date:  1980-09

4.  Direct excitant action of convulsant barbiturates.

Authors:  P R Andrews; R H Evans; G A Johnston; M Willow
Journal:  Experientia       Date:  1981-02-15

5.  Antifibrotic Effects of a Barbituric Acid Derivative on Liver Fibrosis by Blocking the NF-κB Signaling Pathway in Hepatic Stellate Cells.

Authors:  Yuan-Hsi Wang; Fat-Moon Suk; Chao-Lien Liu; Tzu-Lang Chen; Yuh-Ching Twu; Ming-Hua Hsu; Yi-Jen Liao
Journal:  Front Pharmacol       Date:  2020-03-31       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.